Together with their glucose and lipid regulatory activities, the anti-inflammatory effect of PPARα and γ is beneficial in medical conditions where inflammation is one of the major driving forces of disease exacerbation, such as NASH and atherosclerosis. Here, PPARA is linked to metabolic dysfunction-associated steatohepatitis.